AKT1 and Hyperglycemia: Increasing the survival factor sulfiredoxin-1 and senescence marker protein 30 or inhibiting serine/threonine protein kinase 25 can activate the AKT/GSK-3β/Nrf2 pathway and protect RGCs from hyperglycemia-induced oxidative damage [157–159].